2025 to 2026 Legislature · State Senate bill

SB 1149

Relating to: prescription drug cost reporting by manufacturers, making an appropriation, and providing a penalty. (FE)

In committee Last action March 23, 2026: Failed to pass pursuant to Senate Joint Resolution 1

Official bill page and text: docs.legis.wisconsin.gov

Sponsors 9

Prime sponsors

Carpenter, Dassler-Alfheim, Hesselbein, Larson, Pfaff, Ratcliff, Roys, Smith, Spreitzer

Status

In committee as of March 23, 2026. The 2025 to 2026 Legislature serves until the 2027 Legislature convenes on January 4, 2027.

Referred to: Senate Health (from the official referral record)

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 3

Date	Chamber	Action
March 23, 2026	Senate	Failed to pass pursuant to Senate Joint Resolution 1
March 19, 2026	Senate	Read first time and referred to Committee on Health
March 19, 2026	Senate	Introduced by Senators Pfaff, Carpenter, Dassler-Alfheim, Hesselbein, Larson, Ratcliff, Roys, Smith and Spreitzer; cosponsored by Representatives Roe, Subeck, Bare, Brown, Clancy, DeSanto, Emerson, Goodwin, Hong, Joers, Kirsch, Miresse, Moore Omokunde, Sinicki, Snodgrass, Tenorio, Udell, Vining and Anderson

Data: Open States (bulk data, October 1, 2026 monthly extract, which has no roll-call tallies; public data, attribution appreciated). Official record: docs.legis.wisconsin.gov. Bill pages link to the official text, not copied.